Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast Cancer
This study has been terminated.
Study NCT01301911   Information provided by Jiangsu HengRui Medicine Co., Ltd.

First Received on January 28, 2011.   Last Updated on December 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Cipatinib
Sponsors listed in this trial
Jiangsu HengRui Medicine Co., Ltd.
Chinese Academy of Medical Sciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services